Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal. [electronic resource]
Producer: 20170222Description: 2413-2422 p. digitalISSN:- 1619-7089
- Adult
- Cardiomyopathy, Hypertrophic -- diagnostic imaging
- Causality
- Comorbidity
- Coronary Artery Disease -- diagnostic imaging
- Dipyridamole -- administration & dosage
- Female
- Humans
- Italy -- epidemiology
- Longitudinal Studies
- Male
- Perfusion Imaging -- methods
- Positron-Emission Tomography -- methods
- Prevalence
- Reproducibility of Results
- Risk Factors
- Sensitivity and Specificity
- Survival Rate
- Vasodilator Agents -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.